<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">Inflammatory bowel disease</z:e> (IBD), which includes <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (CD) and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC), represents a group of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disorders</z:e> caused by dysregulated immune responses in genetically predisposed individuals </plain></SENT>
<SENT sid="1" pm="."><plain>Genetic markers are associated with disease phenotype and long-term evolution, but their value in everyday clinical practice is limited at the moment </plain></SENT>
<SENT sid="2" pm="."><plain>IBD has a clear immunological background and interleukins play key role in the process </plain></SENT>
<SENT sid="3" pm="."><plain>Almost 130 original papers were revised including meta-analysis </plain></SENT>
<SENT sid="4" pm="."><plain>It is clear these data are very important for understanding the base of the disease, especially in terms of clinical utility and validity, but text often do not available for the doctors use these in the clinical practice nowadays </plain></SENT>
<SENT sid="5" pm="."><plain>We conducted a systematic review of the current literature on interleukin and interleukin receptor gene polymorphisms associated with IBD, performing an electronic search of PubMed Database from publications of the last 10 years, and used the following medical subject heading terms and/or text words: IBD, CD, UC, interleukins and polymorphisms </plain></SENT>
</text></document>